1. Generic Name & Brand Names
Generic Name: Montelukast Sodium
Brand Names:
Singulair® (Global)
Montek® (India)
Lukair® (EU)
Generic equivalents (e.g., "Montelukast")
2. Dosage Forms
Oral:
Chewable Tablets (4 mg, 5 mg)
Film-Coated Tablets (10 mg)
Oral Granules (4 mg/packet)
No injectable/topical forms
3. Drug Class
Leukotriene Receptor Antagonist (LTRA)
Blocks cysteinyl leukotriene (CysLT₁) receptors
Anti-inflammatory, bronchoprotective
4. FDA-Approved Uses
Asthma:
Prophylaxis & chronic treatment (≥1 year)
Prevents bronchoconstriction, reduces inflammation
Allergic Rhinitis (AR):
Seasonal/perennial allergies (≥2 years)
Exercise-Induced Bronchoconstriction (EIB):
Prevention (≥6 years)
Off-label: Chronic urticaria, aspirin-exacerbated respiratory disease (AERD)
5. Side Effects
| Common (≥1%) | Serious (Discontinue Immediately) |
|---|---|
| Headache (18%) | Neuropsychiatric Effects: • Aggression, depression • Hallucinations, suicidal ideation |
| Abdominal pain | Eosinophilia (rare vasculitis) |
| Dizziness | Severe hypersensitivity |
| Fever (children) | Liver injury (elevated LFTs) |
| Rash |
⚠️ Black Box Warning (FDA): Neuropsychiatric events (agitation, suicide risk).
6. Critical Warnings
Neuropsychiatric Risks:
Monitor for behavior changes, nightmares (especially in children/teens).
Contraindications:
Hypersensitivity to montelukast
Phenylketonuria (PKU) - aspartame in chewables
Pregnancy/Lactation:
Category B (limited data) - use only if benefits > risks.
Not for Acute Asthma Attacks:
No bronchodilator effect - keep rescue inhaler (e.g., albuterol).
7. How to Take
| Age Group | Dose & Form | Timing |
|---|---|---|
| Adults ≥15 yrs | 10 mg tablet | Once daily, evening |
| Children 6-14 yrs | 5 mg chewable tablet | Once daily, evening |
| Children 2-5 yrs | 4 mg chewable/granules | Once daily, evening |
| Infants 6-23 mo | 4 mg oral granules | Once daily, evening |
Key Instructions:
Take on empty stomach (1 hr before/2 hrs after food) or consistently with food.
Granules: Mix with applesauce/ice cream (not liquids).
For EIB: Take ≥2 hours before exercise (no additional dose within 24 hrs).
8. Missed Dose
Skip if >12 hours late
Never double dose
9. Drug Interactions
| Medication | Risk |
|---|---|
| Phenobarbital | ↓ Montelukast levels |
| Rifampicin | ↓ Efficacy (CYP2C8/3A4 inducer) |
| Gemfibrozil | ↑ Montelukast levels (monitor) |
10. Storage
Tablets/Granules: 15-30°C (59-86°F); keep granules in foil until use.
Protect from light/moisture.
Clinical Safety Alerts
⚠️ Neuropsychiatric Monitoring:
FDA Mandate (2020): Boxed warning for suicide risk. Report aggression, anxiety, or sleep disturbances immediately.
⚠️ Asthma Control:Not a substitute for inhaled corticosteroids (ICS). Often used as add-on therapy.
⚠️ Pediatric Granules:Avoid mixing with liquids - use soft foods only to ensure full dose delivery.
Efficacy Insights
✅ Asthma:
Reduces exacerbations by 31% vs. placebo (NEJM).
Add-on to ICS improves symptom control (GINA guidelines).
✅ Allergic Rhinitis:Superior to placebo for nasal congestion relief (Ann Allergy Asthma Immunol).
❌ Limitations:Less effective than ICS for moderate-severe asthma.
Montelukast vs. Inhaled Corticosteroids
| Parameter | Montelukast | Fluticasone (ICS) |
|---|---|---|
| Mechanism | LTRA | Anti-inflammatory |
| Onset | 1 day (peak 3 mos) | 2-8 days |
| Delivery | Oral | Inhalation |
| Adverse Effects | Neuropsychiatric | Oral thrush, dysphonia |
| Pediatric Use | >6 months | >4 years |
Patient Counseling Points
"Take at bedtime" – maximizes nighttime asthma control.
"Not for sudden attacks" – always carry rescue inhaler.
"Report mood changes" – nightmares/aggression require immediate review.
"Don't stop abruptly" – no rebound effect but asthma may worsen.
💡 Pro Tip: Combine with antihistamines (e.g., loratadine) for additive allergy relief.
Prescription Status: Requires prescription in most countries (OTC in some Middle Eastern nations).
Comments
Post a Comment